SPDR S&P Biotech ETF
650 hedge funds and large institutions have $12.1B invested in SPDR S&P Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 137 funds opening new positions, 232 increasing their positions, 169 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
650
Holders Change
+99
Holders Change %
+17.97%
% of All Funds
11.53%
Holding in Top 10
16
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+45.45%
% of All Funds
0.28%
New
137
Increased
232
Reduced
169
Closed
33
Calls
$883M
Puts
$4.34B
Net Calls
-$3.46B
Net Calls Change
-$1.53B
Top Buyers
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
$136M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
$36.3M |
| 3 |
Citigroup
New York
|
$848M |
| 4 |
Barclays
London,
United Kingdom
|
$371M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$799M |
